Swing Therapeutics CEO Mike Rosenbluth discusses the company’s fibromyalgia management tool and what’s necessary to make digital therapeutics mainstream.
Swing Therapeutics CEO Mike Rosenbluth discusses the company’s fibromyalgia management tool and what’s necessary to make digital therapeutics mainstream.